EARLY DETECTION OF RENAL TUBULAR DISORDERS USING BIOCHEMICAL MARKERS IN CHILDREN BELOW AGE OF 12 YEARS IN SOUTHERN PUNJAB, PAKISTAN
Main Article Content
Keywords
Renal Tubular Disorders, Biochemical Markers, Children <12 years
Abstract
Objective: To assess the diagnostic potential of serum tissue cystatin-associated factor (t-CAF)
and a panel of urinary biomarkers netrin-1, α-glutathione S-transferase (α-GST), π-glutathione
S-transferase (π-GST), calbindin-D28K, and calprotectin (S100A8/A9) in the early
identification of renal tubular disorders among pediatric populations under 12 years of age in
Southern Punjab.
Materials and methods: This cross-sectional study enrolled 120 children under age 12 years
exhibiting clinical indications of renal tubular dysfunction and 31 sex-matched healthy controls. All
participants were normoalbuminuric and excluded for known metabolic or glomerular diseases. The
patient cohort was further categorized into two subgroups based on clinical severity indices. Serum
t-CAF and urinary biomarker levels were measured using validated enzyme-linked immunosorbent
assay (ELISA) kits under standardized laboratory conditions. Comparative statistical analyses were
performed to evaluate the association of these markers with early tubular injury. Data analysis was
done using SPSS 23 with p-value <0.05 considered as significant.
Results: Serum t-CAF levels were significantly elevated in children with suspected tubular
dysfunction compared to healthy controls (p < 0.05). Similarly, urinary concentrations of netrin1, α-GST, π-GST, and calprotectin were markedly increased in the patient group, indicating
tubular stress or damage. In contrast, no significant difference was observed in urinary calbindin
levels between the groups. Furthermore, biomarker expression did not differ substantially
between the severity-based subgroups, suggesting early and consistent release irrespective of
clinical progression.
Conclusion: Serum t-CAF and specific urinary biomarkers namely netrin-1, α-GST, π-GST, and
calprotectin demonstrates potential as non-invasive, sensitive indicators of early renal tubular
injury in children. Their detection prior to the onset of overt renal dysfunction supports their
utility in preclinical screening, facilitating earlier diagnosis and timely clinical intervention in
at-risk pediatric populations.
References
comorbidities and kidney function estimation in children. Pediatr. Nephrol. 2023, 38, 1867–
1876.
2- Sandino, J.; Luzardo, L.; Morales, E.; Praga, M. Which Patients with Obesity Are at Risk for
Renal Disease? Nephron 2021, 145, 595–603.
3- Czaja-Stolc, S.; Potrykus, M.; Stankiewicz, M.; Kaska, Ł.; Małgorzewicz, S. Pro-Inflammatory
Profile of Adipokines in Obesity Contributes to Pathogenesis, Nutritional Disorders, and
Cardiovascular Risk in Chronic Kidney Disease. Nutrients 2022, 14, 1457.
4- Polidori, N.; Giannini, C.; Salvatore, R.; Pelliccia, P.; Parisi, A.; Chiarelli, F.; Mohn, A. Role of
urinary NGAL and KIM-1 as biomarkers of early kidney injury in obese prepubertal children. J.
Pediatr. Endocrinol. Metab. 2020, 33, 1183–1189.
5- Assadi, F. The Growing Epidemic of Chronic Kidney Disease: Preventive Strategies to Delay
the Risk for Progression to ESRD. Adv. Exp. Med. Biol. 2019, 1121, 57–59.
6- Gul, A.; Yilmaz, R.; Ozmen, Z.C.; Gumuser, R.; Demir, O.; Unsal, V. Assessment of renal
function in obese and overweight children with NGAL and KIM-1 biomarkers. Nutr. Hosp. 2020,
34, 434–442.
7- Medyńska, A.; Chrzanowska, J.; Kościelska-Kasprzak, K.; Bartoszek, D.; Żabińska, M.;
Zwolińska, D. Alpha-1 Acid Glycoprotein and Podocin mRNA as Novel Biomarkers for Early
Glomerular Injury in Obese Children. J. Clin. Med. 2021, 10, 4129.
8- Arampatzis, S.; Chalikias, G.; Devetzis, V.; Konstantinides, S.; Huynh-Do, U.; Tziakas, D. Cterminal fragment of agrin (CAF) levels predict acute kidney injury after acute myocardial
infarction. BMC Nephrol. 2017, 18, 202–210.
9- Ziegon, L.; Schlegel, M. Netrin-1: A Modulator of Macrophage Driven Acute and Chronic
Inflammation. Int. J. Mol. Sci. 2021, 23, 275.
10- Lane, B.R.; Babitz, S.K.; Vlasakova, K.; Wong, A.; Noyes, S.L.; Boshoven, W.; Grady, P.;
Zimmerman, C.; Engerman, S.; Gebben, M.; et al. Evaluation of Urinary Renal Biomarkers for
Early Prediction of Acute Kidney Injury Following Partial Nephrectomy: A Feasibility Study.
Eur. Urol. Focus 2018, 6, 1240–1247.
11- Carnazzo, V.; Redi, S.; Basile, V.; Natali, P.; Gulli, F.; Equitani, F.; Marino, M.; Basile, U.
Calprotectin: Two sides of the same coin. Rheumatology 2024, 63, 26–33.
12- Chen, J.-J.; Fan, P.-C.; Kou, G.; Chang, S.-W.; Chen, Y.-T.; Lee, C.-C.; Chang, C.-H. Metaanalysis: Urinary calprotectin for discrimination of intrinsic and prerenal acute kidney injury. J.
Clin. Med. 2019, 8, 74.
13- John, J.S.; Deepthi, R.V.; Rebekah, G.; Prabhu, S.B.; Ajitkumar, P.; Mathew, G.; Agarwal, I.
Usefulness of urinary calprotectin as a novel marker differentiating functional from structural
acute kidney injury in the critical care setting. J. Nephrol. 2023, 36, 695–704.
14- Mishra, O.P.; Prasad, R. Microalbuminuria and serum cystatin C: Biomarkers for early detection
of kidney injury in children with obesity. Indian J. Pediatr. 2020, 87, 991–992.
15- Önerli Salman, D.; Şıklar, Z.; Çullasİlarslan, E.N.; Özçakar, Z.B.; Kocaay, P.; Berberoğlu, M.
Evaluation of Renal Function in Obese Children and Adolescents Using Serum Cystatin C
Levels, Estimated Glomerular Filtration Rate Formulae and Proteinuria: Which is most Useful?
J. Clin. Res. Pediatr. Endocrinol. 2019, 11, 46–54.
16- Oz-Sig, O.; Kara, O.; Erdogan, H. Microalbuminuria and serum cystatin C in prediction od earlyrenal insufficiency in children with obesity. Indian J. Pediatr. 2020, 87, 1009–1013.
17- Rajeswari, M. Study of Serum C-Terminal Fragment of Agrin as a Marker for Kidney Function
in Patients with Chronic Kidney Disease. Ph.D. Thesis, Dissertation for M.D Degree Branch—
XIII (Biochemistry Department). Department of Biochemistry Thanjavur Medical College,
Tamilnadu, India, May 2020.
18- Soliman, N.S.; Attia, G.F.; Ezat, S.E.; Hagras, M.M. Plasma C-Terminal Agrin Fragment (CAF)
as an Early Marker for Kidney Function in Patients with Chronic Kidney Disease. Med. J. Cairo
Univ. 2019, 87, 3297–3305.
19- Carullo, N.; Zicarelli, M.; Michael, A.; Faga, T.; Battaglia, Y.; Pisani, A.; Perticone, M.; Costa,
D.; Ielapi, N.; Coppolino, G.; et al. Childhood Obesity: Insight into Kidney Involvement. Int. J.
Mol. Sci. 2023, 24, 17400.
20- Medyńska A, Chrzanowska J, Zubkiewicz-Kucharska A, Zwolińska D. New Markers of Early
Kidney Damage in Children and Adolescents with Simple Obesity. Int J Mol Sci. 2024 Oct
7;25(19):10769. doi: 10.3390/ijms251910769. PMID: 39409098; PMCID: PMC11476514.
21- Bazargani B, Moghtaderi M. New Biomarkers in Early Diagnosis of Acute Kidney Injury in
Children. Avicenna J Med Biotechnol. 2022 Oct-Dec;14(4):264-269. PMID: 36504568; PMCID:
PMC9706243.
22- Sriswat N, Kellum J. The role of biomarkers in acute kidney injury. Critic Care Clinics 2020; 36
(1): 125– 40.
23- Bhosale SJ, Atul P, Kulkarni AP. Biomarkers in acute kidney injury. Indian J Crit Care Med
2020; 24 (Suppl 3): S90– S93.
24- Basiratnia M, Kosimov M, Farhadi P, Azimi A, Hooman N. [Urinary calprotectin as a marker to
distinguish functional and structural acute kidney injury in pediatric population]. Iran J Pediatr
2017; 27( 5): e9727. Persian.

